Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010.

Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Shane A, Zhanel GG, Tyrrell GJ, Gilmour MW; Toronto Invasive Bacterial Diseases Network; Canadian Public Health Laboratory Network.

Can J Microbiol. 2012 Aug;58(8):1008-17. doi: 10.1139/w2012-073. Epub 2012 Jul 24.

PMID:
22827750
2.

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.

Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Lovgren M, Tyrrell GJ, Desai S, Sherrard L, Adam H, Gilmour M, Zhanel GG; Toronto Bacterial Diseases Network; Canadian Public Health Laboratory Network.

Can J Microbiol. 2013 Dec;59(12):778-88. doi: 10.1139/cjm-2013-0614. Epub 2013 Oct 21.

PMID:
24313450
3.

Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

Emerg Infect Dis. 2013 Jul;19(7):1074-83. doi: 10.3201/eid1907.121830.

4.

Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006-2010.

Cho EY, Lee H, Choi EH, Kim YJ, Eun BW, Cho YK, Kim YK, Jo DS, Lee HS, Lee J, Kim MN, Kim DS, Lee HJ.

Diagn Microbiol Infect Dis. 2014 Apr;78(4):481-6. doi: 10.1016/j.diagmicrobio.2013.12.016. Epub 2014 Jan 7.

PMID:
24529940
5.

Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine.

Adam HJ, Karlowsky JA, Nichol KA, Gilmour MW, Hoban DJ, Embree J, Zhanel GG.

Microb Drug Resist. 2012 Apr;18(2):176-82. doi: 10.1089/mdr.2011.0197. Epub 2011 Dec 28.

PMID:
22204595
6.

Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.

Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO Jr.

Pediatr Infect Dis J. 2013 Mar;32(3):203-7. doi: 10.1097/INF.0b013e318275614b.

PMID:
23558320
7.

Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002-2010.

Liesenborghs L, Verhaegen J, Peetermans WE, Vandeven J, Flamaing J.

Vaccine. 2013 Mar 1;31(11):1529-34. doi: 10.1016/j.vaccine.2012.11.103. Epub 2012 Dec 20.

PMID:
23261044
9.

Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.

Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L; Catalan study group of invasive pneumococcal disease.

J Infect. 2011 Aug;63(2):151-62. doi: 10.1016/j.jinf.2011.06.002. Epub 2011 Jun 12.

PMID:
21679725
10.

Susceptibility profiles and correlation with pneumococcal serotypes soon after implementation of the 10-valent pneumococcal conjugate vaccine in Brazil.

Mott M, Caierão J, Rosa da Cunha G, Rodrigues Perez LR, Matusiak R, Pilger de Oliveira KR, d'Azevedo PA, Dias C.

Int J Infect Dis. 2014 Mar;20:47-51. doi: 10.1016/j.ijid.2013.11.009. Epub 2013 Dec 31.

11.

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.

Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M; Portuguese Surveillance Group for the Study of Respiratory Pathogens.

Clin Microbiol Infect. 2008 Sep;14(9):835-43. doi: 10.1111/j.1469-0691.2008.02031.x.

12.

Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.

Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW.

Clin Infect Dis. 2009 Jul 15;49(2):205-12. doi: 10.1086/599827.

PMID:
19508165
13.

Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.

Imöhl M, Reinert RR, van der Linden M.

Int J Med Microbiol. 2010 Apr;300(4):237-47. doi: 10.1016/j.ijmm.2009.05.005. Epub 2009 Jul 14.

PMID:
19604721
14.

Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.

Golden AR, Adam HJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA).

Vaccine. 2016 May 17;34(23):2527-30. doi: 10.1016/j.vaccine.2016.03.058. Epub 2016 Apr 13.

PMID:
27085174
15.

Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.

Tocheva AS, Jefferies JM, Rubery H, Bennett J, Afimeke G, Garland J, Christodoulides M, Faust SN, Clarke SC.

Vaccine. 2011 Jun 10;29(26):4400-4. doi: 10.1016/j.vaccine.2011.04.004. Epub 2011 Apr 17.

PMID:
21504773
17.

Redistribution of Streptococcus pneumoniae Serotypes After Nationwide 13-valent Pneumococcal Conjugate Vaccine Program in Children in Northern Taiwan.

Cho YC, Chiu NC, Lu CY, Huang DT, Huang FY, Chang LY, Huang LM, Chi H.

Pediatr Infect Dis J. 2017 Dec;36(12):e334-e340. doi: 10.1097/INF.0000000000001664.

PMID:
28650416
18.

European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.

Navarro Torné A, Dias JG, Quinten C, Hruba F, Busana MC, Lopalco PL, Gauci AJ, Pastore-Celentano L; ECDC country experts for pneumococcal disease.

Vaccine. 2014 Jun 17;32(29):3644-50. doi: 10.1016/j.vaccine.2014.04.066. Epub 2014 May 2.

PMID:
24795228
19.

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009.

Ho PL, Chiu SS, Ang I, Lau YL.

Vaccine. 2011 Apr 12;29(17):3270-5. doi: 10.1016/j.vaccine.2011.02.025. Epub 2011 Feb 23.

PMID:
21352937
20.

Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines.

McElligott M, Vickers I, Cafferkey M, Cunney R, Humphreys H.

Vaccine. 2014 Jun 12;32(28):3495-500. doi: 10.1016/j.vaccine.2014.04.047. Epub 2014 May 2.

PMID:
24795223

Supplemental Content

Support Center